EconPapers    
Economics at your fingertips  
 

Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations

Xiaowen Xie, Olivia Zhang, Megan J. R. Yeo, Ceejay Lee, Ran Tao, Stefan A. Harry, N. Connor Payne, Eunju Nam, Leena Paul, Yiran Li, Hui Si Kwok, Hanjie Jiang, Haibin Mao, Jennifer L. Hadley, Hong Lin, Melissa Batts, Pallavi M. Gosavi, Vincenzo D’Angiolella, Philip A. Cole, Ralph Mazitschek, Paul A. Northcott, Ning Zheng () and Brian B. Liau ()
Additional contact information
Xiaowen Xie: University of Washington
Olivia Zhang: Harvard University
Megan J. R. Yeo: Harvard University
Ceejay Lee: Harvard University
Ran Tao: St. Jude Children’s Research Hospital
Stefan A. Harry: Harvard University
N. Connor Payne: Harvard University
Eunju Nam: Harvard Medical School
Leena Paul: St. Jude Children’s Research Hospital
Yiran Li: St. Jude Children’s Research Hospital
Hui Si Kwok: Harvard University
Hanjie Jiang: Harvard Medical School
Haibin Mao: University of Washington
Jennifer L. Hadley: St. Jude Children’s Research Hospital
Hong Lin: St. Jude Children’s Research Hospital
Melissa Batts: St. Jude Children’s Research Hospital
Pallavi M. Gosavi: Harvard University
Vincenzo D’Angiolella: University of Edinburgh
Philip A. Cole: Harvard Medical School
Ralph Mazitschek: Broad Institute of MIT and Harvard
Paul A. Northcott: St. Jude Children’s Research Hospital
Ning Zheng: University of Washington
Brian B. Liau: Harvard University

Nature, 2025, vol. 639, issue 8053, 241-249

Abstract: Abstract Cancer mutations can create neomorphic protein–protein interactions to drive aberrant function1,2. As a substrate receptor of the CULLIN3-RING E3 ubiquitin ligase complex, KBTBD4 is recurrently mutated in medulloblastoma3, the most common embryonal brain tumour in children4. These mutations impart gain-of-function to KBTBD4 to induce aberrant degradation of the transcriptional corepressor CoREST5. However, their mechanism remains unresolved. Here we establish that KBTBD4 mutations promote CoREST degradation through engaging HDAC1/2 as the direct target of the mutant substrate receptor. Using deep mutational scanning, we chart the mutational landscape of the KBTBD4 cancer hotspot, revealing distinct preferences by which insertions and substitutions can promote gain-of-function and the critical residues involved in the hotspot interaction. Cryo-electron microscopy analysis of two distinct KBTBD4 cancer mutants bound to LSD1–HDAC1–CoREST reveals that a KBTBD4 homodimer asymmetrically engages HDAC1 with two KELCH-repeat β-propeller domains. The interface between HDAC1 and one of the KBTBD4 β-propellers is stabilized by the medulloblastoma mutations, which insert a bulky side chain into the HDAC1 active site pocket. Our structural and mutational analyses inform how this hotspot E3–neosubstrate interface can be chemically modulated. First, we unveil a converging shape-complementarity-based mechanism between gain-of-function E3 mutations and a molecular glue degrader, UM171. Second, we demonstrate that HDAC1/2 inhibitors can block the mutant KBTBD4–HDAC1 interface and proliferation of KBTBD4-mutant medulloblastoma cells. Altogether, our work reveals the structural and mechanistic basis of cancer mutation-driven neomorphic protein–protein interactions.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-024-08533-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:639:y:2025:i:8053:d:10.1038_s41586-024-08533-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-024-08533-3

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-04-02
Handle: RePEc:nat:nature:v:639:y:2025:i:8053:d:10.1038_s41586-024-08533-3